1. Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: Model prediction and clinical confirmation. (24th May 2014) Authors: Stroh, Mark; Talaty, Jennifer; Sandhu, Punam; McCrea, Jacqueline; Patnaik, Amita; Tolcher, Anthony; Palcza, John; Orford, Keith; Breidinger, Sheila; Narasimhan, Narayana; Panebianco, Deborah; Lush, Richard; Papadopoulos, Kyriakos P.; Wagner, John A.; Trucksis, Michele; Agrawal, Nancy Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Transcriptomic biomarkers to assess the liver and metabolic responses associated with bioactivation mechanisms of drug induced liver injury. Issue 1 (January 2019) Authors: Monroe, James; Tanis, Keith; Podtelezhnikov, Alexei; Nguyen, Truyen; Lynch, Donna; Palamanda, Sam Machotka; Pippert, Todd; Bailey, Wendy; Pacchione, Stephen; Aslamkhan, Amy; Johnson, Timothy; Cabalu, Tamara; Daublain, Pierre; Miller, Randy; Cox, Kathleen; Glaab, Warren; Evers, Raymond; Mitra, Kau... Journal: Drug metabolism and pharmacokinetics Issue: Volume 34:Issue 1(2019)Supplement Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗